At ELRIG’s Drug Discovery 2026, the Drug Discovery News team spoke with Del Trezise, Chair of ELRIG, about how collaboration can help drive scientific progress and bring emerging innovations closer to real-world use. Trezise highlights the value of connecting academia, industry, investors, and other stakeholders, particularly as early-stage companies seek to commercialize and industrialize their technologies.
In this interview, Trezise discusses ELRIG’s role in connecting early innovators with the wider drug discovery community, as well as the importance of digital skills, trusted networks, and professional collaboration. He also shares advice for founders and technology developers on demonstrating scientific claims, identifying target users, understanding market needs, and gathering honest feedback. Looking ahead, Trezise reflects on ELRIG’s efforts to strengthen international scientific connections and share knowledge across a broader global community.








